Cargando…
Potentials and limitations of microorganisms as renal failure biotherapeutics
Renal insufficiency leads to uremia, a complicated syndrome. It thus becomes vital to reduce waste metabolites and regulate water and electrolytes in kidney failure. The most common treatment of this disease is either dialysis or transplantation. Although these treatments are very effective, they ar...
Autores principales: | Jain, Poonam, Shah, Sapna, Coussa, Razek, Prakash, Satya |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726052/ https://www.ncbi.nlm.nih.gov/pubmed/19707412 |
Ejemplares similares
-
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
por: Prakash, Satya, et al.
Publicado: (2011) -
Oral Microencapsulated Live Saccharomyces cerevisiae Cells for Use in Renal Failure Uremia: Preparation and In Vivo Analysis
por: Coussa, Razek, et al.
Publicado: (2010) -
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
por: Prakash, Satya, et al.
Publicado: (2008) -
Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases
por: Kumar, Manoj, et al.
Publicado: (2012) -
Chrysophanol: A Natural Anthraquinone with Multifaceted Biotherapeutic Potential
por: Prateeksha,, et al.
Publicado: (2019)